Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2014 | 03-2013 | 03-2012 | 12-2011 | 03-2011 | |
| Sales | 759,285 | 0 | 0 | 0 | 107,720 |
| Cost of Goods | 179,279 | N/A | N/A | N/A | 44,610 |
| Gross Profit | 580,006 | N/A | N/A | N/A | 63,110 |
| Operating Expenses | 150,032 | 0 | 0 | 0 | 30,320 |
| Operating Income | 430,253 | N/A | N/A | N/A | 33,400 |
| Interest Expense | 0 | 0 | 0 | 0 | 770 |
| Other Income | 13,654 | 0 | 0 | 0 | -180 |
| Pre-tax Income | 443,907 | 0 | 0 | 0 | 32,450 |
| Income Tax | 82,729 | N/A | N/A | N/A | 6,360 |
| Net Income Continuous | 361,178 | N/A | N/A | N/A | 52,398 |
| Net Income Discontinuous | -319 | N/A | N/A | N/A | -130 |
| Minority Interests | 472 | N/A | N/A | N/A | N/A |
| Net Income | $360,387 | $N/A | $N/A | $N/A | $25,950 |
| EPS Basic Total Ops | 8.14 | N/A | N/A | N/A | 1.33 |
| EPS Basic Continuous Ops | 8.16 | N/A | N/A | N/A | 1.33 |
| EPS Basic Discontinuous Ops | -0.01 | N/A | N/A | N/A | 0.00 |
| EPS Diluted Total Ops | 8.14 | N/A | N/A | N/A | 1.27 |
| EPS Diluted Continuous Ops | 8.16 | N/A | N/A | N/A | 1.27 |
| EPS Diluted Discontinuous Ops | -0.01 | N/A | N/A | N/A | 0.00 |
| EBITDA(a) | $446,820 | $N/A | $N/A | $N/A | $38,100 |